Assessment of islet function following islet and pancreas transplantation

被引：8

作者：

Dy E.C. ^{[1
]}

Harlan D.M. ^{[1
]}

Rother K.I. ^{[1
]}

机构：

[1] Diabetes Branch, National Institute of Diabetes, National Institutes of Health, Bethesda, MD 20892

来源：

Current Diabetes Reports | 2006年 / 6卷 / 4期

基金：

美国国家卫生研究院;

关键词：

Islet Transplantation; Pancreas Transplantation; Islet Function; Acute Insulin Response; Insulin Independence;

D O I：

10.1007/s11892-006-0067-y

中图分类号：

学科分类号：

摘要：

Pancreas and islet transplant recipients are monitored using various metabolic and imaging methods. The inaccessibility of the transplanted whole pancreas and of the isolated islets poses specific problems (eg, all assessment techniques are indirect). Although successful pancreas transplantation typically restores normal glucose homeostasis, islet transplantation into the liver does not completely normalize islet hormone secretion and glucose metabolism. Development of better testing strategies, such as direct islet imaging, will significantly advance the field. Copyright © 2006 by Current Science Inc.

引用

页码：316 / 322

页数：6

共 53 条

[1]

Gruessner A.C., Sutherland D.E., Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004, Clin Transplant, 19, pp. 433-455, (2005)

[2]

Sutherland D.E., Gruessner R.W., Dunn D.L., Et al., Lessons learned from more than 1,000 pancreas transplants at a single institution, Ann Surg, 233, pp. 463-501, (2001)

[3]

Robertson R.P., Davis C., Larsen J., Et al., Pancreas transplantation for patients with type 1 diabetes, Diabetes Care, 26, SUPPL. 1, (2003)

[4]

Landgraf R., Impact of pancreas transplantation on diabetic secondary complications and quality of life, Diabetologia, 39, pp. 1415-1424, (1996)

[5]

Venstrom J.M., McBride M.A., Rother K.I., Et al., Survival after pancreas transplantation in patients with diabetes and preserved kidney function, JAMA, 290, pp. 2817-2823, (2003)

[6]

Joist H., Brennan D.C., Coyne D.W., Anemia in the kidney-transplant patient, Adv Chronic Kidney Dis, 13, pp. 4-10, (2006)

[7]

Boratynska M., Banasik M., Watorek E., Et al., Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients, Transplant Proc, 38, pp. 101-104, (2006)

[8]

Williams D., Haragsim L., Calcineurin nephrotoxicity, Adv Chronic Kidney Dis, 13, pp. 47-55, (2006)

[9]

Najarian J.S., Sutherland D.E., Matas A.J., Et al., Human islet transplantation: A preliminary report, Transplant Proc, 9, pp. 233-236, (1977)

[10]

Largiader F., Kolb E., Binswanger U., A long-term functioning human pancreatic islet allotransplant, Transplantation, 29, pp. 76-77, (1980)

← 1 2 3 4 5 6 →